NOT-AT-22-011: NCCIH Announces Availability of Frequently Asked Questions (FAQs) for RFA-AT-22-003: HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)

NCCIH Announces Availability of Frequently Asked Questions (FAQs) for RFA-AT-22-003: HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)

Notice Number:

NOT-AT-22-011

Key Dates

Release Date:

February 8, 2022

Related Announcements

RFA-AT-22-003: HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)

Issued by

National Center for Complementary and Integrative Health (NCCIH)

Purpose

The purpose of this Notice is to inform potential applicants that a set of responses to Frequently Asked Questions (FAQs) regarding RFA-AT-22-003: HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) has been posted at the following link:

https://www.nccih.nih.gov/grants/frequently-asked-questions-heal-initiative-developing-quantitative-imaging-and-other-relevant-biomarkers-of-myofascial-tissues-for-clinical-pain-management-r61r33-clinical-trial-required

Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.

Inquiries

Please direct all inquiries to:

HEAL Myofascial RFA Program Team

Email: myofascial_pain_heal@mail.nih.gov